Unknown

Dataset Information

0

Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.


ABSTRACT: We previously isolated an IL-11-mimic motif (CGRRAGGSC) that binds to IL-11 receptor (IL-11R) in vitro and accumulates in IL-11R-expressing tumors in vivo. This synthetic peptide ligand was used as a tumor-targeting moiety in the rational design of BMTP-11, which is a drug candidate in clinical trials. Here, we investigated the specificity and accessibility of IL-11R as a target and the efficacy of BMTP-11 as a ligand-targeted drug in lung cancer. We observed high IL-11R expression levels in a large cohort of patients (n = 368). In matching surgical specimens (i.e., paired tumors and nonmalignant tissues), the cytoplasmic levels of IL-11R in tumor areas were significantly higher than in nonmalignant tissues (n = 36; P = 0.003). Notably, marked overexpression of IL-11R was observed in both tumor epithelial and vascular endothelial cell membranes (n = 301; P < 0.0001). BMTP-11 induced in vitro cell death in a representative panel of human lung cancer cell lines. BMTP-11 treatment attenuated the growth of subcutaneous xenografts and reduced the number of pulmonary tumors after tail vein injection of human lung cancer cells in mice. Our findings validate BMTP-11 as a pharmacologic candidate drug in preclinical models of lung cancer and patient-derived tumors. Moreover, the high expression level in patients with non-small cell lung cancer is a promising feature for potential translational applications.

SUBMITTER: Cardo-Vila M 

PROVIDER: S-EPMC4973658 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4490036 | BioStudies
2017-01-01 | S-EPMC5544306 | BioStudies
1000-01-01 | S-EPMC5138853 | BioStudies
2015-01-01 | S-EPMC4490100 | BioStudies
1996-01-01 | S-EPMC1217647 | BioStudies
1996-01-01 | S-EPMC1217939 | BioStudies
2018-01-01 | S-EPMC5925790 | BioStudies
2008-01-01 | S-EPMC2565473 | BioStudies
2014-01-01 | S-EPMC4117465 | BioStudies
1998-01-01 | S-EPMC1219407 | BioStudies